CXCR3 is expressed on the surface of these cells, and RANKL can be secreted under the stimulation of IL-6 to induce osteoclast differentiation and ultimately cause bone destruction in RA patients (14). This evidence concerns the gene TNFSF11 and rheumatoid arthritis.